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INTRODUCTION 
 
Aging is commonly defined as a time-dependent 
decrease in the functional and structural integrity of an 
organism. Despite the ubiquity of aging in all living 
organisms, the molecular mechanisms responsible still 
require further elucidation. According to recent studies, 
aging differs phenotypically among individuals, 
including monozygotic twins [1,2] and within tissues 
from the same individuals [3]. Researchers have 
observed an age-related increase in variability in the 
epigenome [4,5] and transcriptome [6] of genetically 
identical samples, which may underlie the phenotypic 
differences. Age-related expression variability has been 
detected in many different cell and tissue types 
including mice stem cells, cardiomyocytes and immune 
cells [7–9], rat neural retina [10], fruit-fly, mice and 
human brain [6,11–14] as well as human pancreas, lung, 
blood, skin, fat and human fibroblasts in vitro [13,15–
17]. Despite these reports, there is no agreement on the 
underlying mechanisms, extent and functional 
consequences. Suggested mechanisms include somatic 
[7,15] and germline mutations [11,17], changes in the 
DNA methylation [9,17,18] and chromatin 
modifications [5] and resulting chromatin compaction 
[12] as well as global dysregulation, caused by the 
change in transcription factor or miRNA expression 
[19].  
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ABSTRACT 
 
Aging is broadly defined as a time-dependent progressive decline in the functional and physiological integrity of 
organisms. Previous studies and evolutionary theories of aging suggest that aging is not a programmed process 
but reflects dynamic stochastic events. In this study, we test whether transcriptional noise shows an increase 
with age, which would be expected from stochastic theories. Using human brain transcriptome dataset, we 
analyzed the heterogeneity in the transcriptome for individual genes and functional pathways, employing 
different analysis methods and pre-processing steps. We show that unlike expression level changes, changes in 
heterogeneity are highly dependent on the methodology and the underlying assumptions. Although the 
particular set of genes that can be characterized as differentially variable is highly dependent on the methods, 
we observe a consistent increase in heterogeneity at every level, independent of the method. In particular, we 
demonstrate a weak but reproducible transcriptome-wide shift towards an increase in heterogeneity, with 
twice as many genes significantly increasing as opposed to decreasing their heterogeneity. Furthermore, this 
pattern of increasing heterogeneity is not specific but is associated with a wide range of pathways. 
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Both genome-wide and hypothesis-driven approaches 
have been employed to explore the extent of expression 
variability with age. Among the former, some show a 
transcriptome-wide increase [6,9,12,13,15], while 
others focus only on those genes showing significant 
changes in their variability. Brinkmeyer-Langford et al. 
[11] report that an equal number of genes significantly 
increase or decrease their expression variability, 
whereas a recent study from Vinuela et al. [17] shows 
more genes decreasing rather than increasing their 
expression variability [17]. Hypothesis-driven studies 
mostly show an increase in variability for the genes 
measured [7,8,16], whereas Warren et al. [20] suggest 
this might be specific only to the non-renewing tissues. 
Similarly, Ximerakis et al. [14] show that change in 
transcription variability is in different directions in 
different cell types of mouse brain. The reports also 
vary in terms of the functional association of this 
variability. While some consider that increase in 
variability is widespread [6,12], others report that 
variability is concentrated in various cellular functions 
[10,11,18,21] – although these functions also differ 
between reports. 
 
Age-dependent change in the expression variability is 
difficult to address due to the inherent noise in 
expression and the influence of other factors on 
variability. Thus, the data pre-processing steps to 
disentangle variability from the biological and technical 
confounders is of importance. Another technical aspect 
is the method to measure the change in the variability. 
Most studies tested for age-related change in the 
expression variability using either grouped (Bartlett’s 
test, Levene’s test, permutation test) [7,11,20] or 
regression-based tests (linear and loess regression) 
[6,10,17,18], with a few others using correlation-based 
approaches (gene co-expression, intra-class 
correlations) [21,22]. However, to our best knowledge, 
the effects of different batch-correction strategies and 
different methods to measure variability have not been 
explored on the same data. 
 
In this study, we undertook a comprehensive 
investigation of the aging-related change in expression 
variability, using human brain expression dataset. We 
employed different pre-processing and variability 
measures and analyzed transcriptome-wide and gene-
level changes in gene expression variability and the 
associated functions.  
 
RESULTS 
 
In order to study the change in gene expression 
variability during aging, we used one of the biggest 
published human brain transcriptome datasets, 
generated using microarray technology [23]. We limited 
the age range to between 20 and 80 years (Figure 1A), 
resulting in RNA expression data for 147 prefrontal 
cortex samples. We excluded prenatal, infant and 
childhood samples (up to 20 years old) because their 
expression levels are inherently coupled with 
developmental processes in the brain. We applied four 
batch correction strategies to account for technical and 
biological confounders (Supplemental Figure 1): i) only 
 
 
Figure 1. Data characterization. (A) Age distribution of the samples used in the study. (B) Bar plot of the number of genes 
differentially expressed with aging identified after regression and SVA correction and their overlap. The color represents direction of 
change: yellow – genes upregulated and blue – downregulated with age.  
 
www.aging-us.com 2255 AGING 
quantile normalization (QN), ii) QN followed by linear 
regression (regression), iii) QN followed by ComBat 
[24], and iv) QN followed by Surrogate Variable 
Analysis (SVA) [25]. Regression and ComBat are 
supervised approaches, i.e. known covariates should be 
supplied to the algorithm, whereas SVA estimates 
covariates from the data. We provide the results from 
Regression and SVA in the main text to include one 
supervised and one unsupervised approach. The results 
from other correction strategies are given in 
Supplemental Data in comparison with the Regression 
and SVA approaches (Supplemental Figures 2-8). 
 
Analysis of the differentially expressed genes 
 
First, we defined differentially expressed (DE) genes, 
based on the significance of the regression coefficients 
(FDR corrected p <= 0.05) for the linear model using 
the gene expression values as the dependent and age as 
the independent variable (see Methods). By applying 
two different pre-processing approaches on the data 
prior to DE estimation the number of DE genes was 
very different. SVA correction yielded 3499 DE genes, 
compared with 881 DE genes found by regression 
(Figure 1B, Supplemental Table 1). Nevertheless, 854 
genes overlapped between the SVA and regression 
results, which constituted a quarter of genes found after 
SVA and 96% of the genes identified after regression 
correction. Quite a high overlap was consistent with the 
strong correlation between the expression level changes 
for the regression and SVA corrected data (Spearman ρ 
= 0.85, Supplemental Figure 3A).  
 
To explore the biological processes affected by these 
changes in gene expression, gene set enrichment 
analysis was performed separately on the regression and 
SVA corrected data (Supplemental Table 2). It revealed 
125 (out of 191 (regression) and 160 (SVA) categories) 
shared Gene Ontology Biological Process (GO BP) 
categories that were downregulated in the aging brain. 
Cognitive-function related GO terms, such as 
modulation of synaptic transmission, learning or 
memory, constituted a substantial fraction of these GO 
terms. In contrast, the number of the upregulated GO 
terms was much smaller and only 8 GO terms 
overlapped (out of 22 (regression) and 12 (SVA) 
categories) between the correction approaches, 
including detoxification, stress response to metal ions 
and cilium organization GO categories (see 
Supplemental Table 2). 
 
Analysis of the differentially variable genes  
 
Two different strategies were employed to measure 
change in the gene expression variability with age, 
namely continuous and grouped approaches. The 
continuous approach detects continuous monotonic 
change in variation from 20 to 80 years of age. The 
grouped approach compares the gene expression 
variation between two age groups: young (20 - 40 years 
old, N = 53) and old (60 - 80 years old, N = 22). Figure 
2 illustrates the principles of these approaches and 
shows that the change in variability can be combined 
with any dynamics in the mean gene expression 
(upregulation, downregulation, no change). We checked 
if the changes in gene expression variability were 
confounded by the changes in gene expression level, but 
did not observe any relationship (Supplemental Figure 
10, Fisher’s test p = 0.11, Odds ratio = 1.05).  
 
In the continuous approach, we first fit a linear model 
to explain age-dependent change in expression (Figure 
2, first column) and then used the residuals from this 
model to represent the variability. To measure change in 
the expression variability with age, we calculated the 
Spearman correlation coefficient (∆var(ρ)) between the 
absolute value of residuals and age (Figure 2, middle 
column). The ∆var(ρ) measures ranged between -0.32 
and 0.36 and were normally distributed (Shapiro-Wilk 
test, p > 0.05, see Methods) (Figure 3A). The 
distributions were significantly shifted towards positive 
values for both correction methods (median values 
range between 0.01 to 0.03, Wilcoxon test, p < 2.2e-16). 
Although the shift in the distribution was small, 57% to 
63% percent of the genes showed increase in variability 
with age. However, we noted that the changes in 
variability calculated for each gene, using regression- 
and SVA-corrected data, were only weakly correlated, 
ρ(∆var(ρregres), ∆var(ρSVA)) = 0.35 (Figure 3B). 
 
In the grouped approach, we first generated a 
distribution of expected variability in gene expression 
for the young individuals and treated it as a null 
distribution to compare with the variability from the old 
individuals. We used interquartile range (IQR) as a 
measure of variability because it is robust to outliers. In 
order to calculate a distribution of expected variability 
in the young group, we randomly selected a subsample 
of 22 individuals (the number of samples in the old 
group) from the 53 individuals in the young group 10 
000 times and calculated IQR. The change in 
variability, ∆var (IQR), was measured as a fractional 
change in the IQR between old and young groups (see 
Methods). The p-value was determined by calculating 
how many times we observed value as extreme as 
IQRold (see Methods). The distributions of change in 
variability, ∆var(IQR), were moderately skewed to the 
right and ranged from -0.70 up to 2.10 for the regression 
corrected data and from -0.78 up to 1.71 for the SVA 
corrected data (Figure 3C). The skew to the right was 
expected given that we calculate variability change as a 
fraction and, thus,  it  was  more  sensitive to increase in  
www.aging-us.com 2256 AGING 
  
 
 
Figure 2. Changes in gene expression and its variability with age for some individual genes, using the different 
approaches. Example genes are chosen that increase (A), or decrease (B) expression variability with age, when the mean gene 
expression either increases, does not change or decreases. The types of change, for expression and variability respectively, is shown in 
the parenthesis following the gene name, for each row. Genes were selected to have the biggest absolute values of ∆var(ρ) and 
∆var(IQR) as well as demonstrate significant increase, decrease or no change in the expression level with age. The first column to the 
left illustrates mean expression level (regression-corrected) plotted against individual’s age on the x0.25 – transformed scale. The 
regression line is colored in blue, with the β1 coefficient from the linear regression shown on the graph.  The middle column illustrates 
the continuous approach to measure differential variability. Absolute values of the residuals (in red) from the regression line are 
plotted against age and the regression line between residuals and age (in blue) is drawn for illustrative purposes. The Spearman 
correlation estimates, ∆var(ρ)  between the residuals and age are displayed on the graph and used in the subsequent analysis. The last 
column on the right illustrates the grouped approach to calculate differential variability. Gene expression levels (regression-corrected) 
of the individuals from the “young” (20 – 40 years old) and “old” (60 – 80 years old) groups are represented in the corresponding 
boxplots. A small random deviation (jitter) from the x-axis is applied for better visualization. ∆var(IQR), the fractional change in the 
variability in the “old” group, as compared to the “young”, is displayed on the graph. 
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variability. In both cases, the distributions demonstrated 
a significant deviation from zero (Wilcox test, p-value < 
2.2e-16 both for regression and SVA corrections). The 
data revealed that 6% and 2% more genes showed more 
variability in the old group, for regression and SVA 
approaches respectively. Similar to the continuous 
approach, the effect sizes calculated using regression 
and SVA corrected data correlated weakly 
ρ(∆var(IQRregres), ∆var(IQRSVA)) = 0.24, Figure 3D). 
 
Gene-level differential variability 
 
We then asked if we could detect any genes with a 
significant change in variability. Using the continuous 
approach, we did not detect any significant change in 
variability with age after the multiple testing correction 
(Supplemental Table 3). The grouped approach leads to 
741 and 746 differentially variable (DV) genes (FDR 
corrected p ≤ 0.05) using the regression and SVA 
correction, respectively (Figure 4A, Supplemental Table 
4). However, the two sets of DV genes identified only 
have 83 genes in common (Figure 4A), one of which 
shows an opposite direction of change in the two sets. 
The correlation between ∆var (IQR) for regression and 
SVA corrected data is weak (ρ = 0.24), but correlation 
increases when we select only the common DV genes (ρ 
= 0.44) (Figure 4B). In agreement with our overview 
analysis above, we find twice as many DV genes with an 
increase in variability as those that decrease variability, 
using both correction methods: i) 533 genes increase and 
208 decrease their variability in the regression 
correction, ii) 505 genes increase and 241 decrease their 
variability in the SVA correction (Figure 4A).  
 
Differential variability of functional groups 
 
Following the individual gene analysis, we explored 
whether genes that tend to increase or decrease 
variability with age are localized in particular functional 
groups. We performed multiple gene set enrichment 
 
 
Figure 3. Comparison of the change in the variability addressed using continuous and grouped approaches, regression 
and SVA correction. Distributions of the ∆var-measures for all the genes (n = 16675) obtained in the continuous (A) and grouped (C) 
approaches. Increase in the variability with age, ∆var > 0, is colored in orange, while decrease in variability, ∆var < 0, is marked in blue. 
The red dashed  line depicts median of the distribution. The ∆var(ρ) distributions are normal with their mean and median values equal 
to 0.03 and 0.02 for regression and SVA, respectively; The ∆var(IQR)  distributions are moderately skewed: skewness values are 0.66 
and 0.68 for regression and SVA, respectively. The mean and median values of the ∆var(IQR) distribution are 0.05 and 0.02 for 
regression and 0.04 and 0.01 for SVA, respectively. Hexagonal heat maps illustrate relationship between regression and SVA-corrected 
measures of the variability for each gene, obtained in continuous - ∆var(ρ) (B) and grouped - ∆var(IQR) (D) approaches. The color 
gradient represents the density of the data. The linear regression line and the Spearman correlation estimate, ρ, for the corresponding 
variables are shown on each graph.  
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analyses (GSEA) using the change in the variability 
with age (∆var) measures obtained in the continuous 
and grouped approaches on the gene sets from KEGG 
and Biological Process GO categories (Supplemental 
Tables 5, 6). We observed no genome-level significant 
enrichment in particular functional groups on the data 
either from the continuous (SVA correction), or the 
grouped approach (Regression and SVA corrections). 
However, we found that 4 pathways, namely beta-
Alanine metabolism, Ras signaling pathway, 
Phosphatidylinositol signaling system, Bacterial 
invasion of epithelial cells (FDR corrected p ≤ 0.05) 
were enriched among the genes showing more 
variability of expression in the continuous approach 
(Regression correction).  These pathways had positive 
normalized enrichment scores (NES) i.e. enrichment for 
the genes that increase variability with age. Moreover, 
these pathways also had positive NES for other 
approaches, even though they were not significant 
(Supplemental Table 5). 
 
Distribution of the DV genes in the pathways  
 
The gene set enrichment analysis shows if there are 
particular gene sets that include the genes with the 
highest increase or decrease. Failing to detect such 
functional categories, we asked how the variability 
measures for the genes were distributed in the different 
functional groups of genes. For each of 310 KEGG 
pathways, encompassing 5922 unique genes, we 
analyzed the distributions of  ∆var measures 
(Supplemental Table 7), focusing on the median value 
for the change in variability (Figure 5A, B). In line with 
the overall tendencies we observed (Figure 3A, C), the 
majority of pathways contained a larger number of 
genes that become more variable with age, irrespective 
of the approach or correction method used. Although 
the increase in variability is ubiquitous and is observed 
across the majority of the pathways (74-94%), the 
increase is small (the mean value for the shift in 
distributions range between 0.021 and 0.033) – in 
accordance with the small, but significant increase 
observed in the distribution for all genes. Since the 
pathways are not mutually exclusive, we checked if 
there are particular genes that are present in many 
different pathways and cause the shift. However, no 
significant correlation between the pathway 
membership of gene and its variability measure (∆var) 
was detected (Supplemental Figure 11). We repeated 
the analysis using GO Biological Process categories and 
observed a similar trend (see Supplemental Information, 
Supplemental Table 7, 8). 
 
 
Figure 4. Differentially variable genes (grouped approach). (A) A bar plot of the differentially variable genes in aging identified 
using the grouped approach (regression, SVA correction and their overlap), direction of the change in the variability is shown in color: 
orange - increase in variability in aging, blue – decrease in variability (The single common gene, which shows inconsistency between 
approaches, is not displayed on the graph). (B) The relationship between the variability measures calculated using the grouped 
approach, ∆var (IQR), for regression and SVA-corrected data. Differentially variable (DV) genes identified in both corrections are 
highlighted in red (Spearman ρ = 0.44); DV genes identified in either regression, or SVA - in blue (Spearman ρ = 0.20); genes, that were 
not found to be differentially variable in any of the approaches – in grey (Spearman ρ = 0.20). 
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DISCUSSION 
 
Using one of the largest publicly available human brain 
expression datasets, we have investigated the change in 
the variability of the gene expression with age. We 
applied and compared different approaches to identify 
differentially variable genes and correction strategies to 
adjust for the confounders. Our comparison showed that 
the correction strategy plays a pivotal role in identifying 
the specific set of differentially variable (DV) genes. 
However, irrespective of the approach and correction 
method used, we observed a transcriptome-wide 
increase in the gene expression variability, i.e. more 
genes showed a tendency to increase than to decrease 
expression variability with age. We also showed that 
most of the functional processes (as defined in KEGG 
and GO) were susceptible to the aging-related increase 
in the expression variability.  
 
The difference between the continuous and grouped 
approaches can be explained by the power and initial 
assumptions of each method. While the continuous 
approach assumes a linear change in expression with 
age0.25 (see Supplemental Figure 4 for the results 
showing high concordance between models using age 
vs. age0.25 – correlation coefficient (ρ) ranges between 
0.995 to 0.997), the grouped approach analyzes each 
age-group within itself and is not sensitive to different 
dynamics of gene expression change. However, the 
grouped approach requires expression levels to be 
similar within the young and old groups. The 
continuous approach is well suited to detect monotonic 
changes in variability, whereas the grouped approach 
can detect switch-like changes, e.g. when variability 
stays the same throughout the lifespan but changes 
abruptly at the age of 60. In contrast, the continuous 
approach focuses on the whole aging period, while the 
grouped approach overlooks the middle-age group (40-
60). Finally, both methods are vulnerable to power 
issues as the continuous approach uses Spearman 
correlation, a non-parametric method, and the grouped 
approach analyses only a subset of the data. Thus, we 
compared the variability measure of each gene, 
calculated using these two approaches. The variability 
measures are moderately correlated (ρ = 0.43) for the 
regression correction and strongly correlated (ρ = 0.71) 
for the SVA correction (Supplemental Figure 9). 
Overall, the differences in the results using these two 
 
 
Figure 5. Distributions of the variability measures (∆var) obtained using a combination of continuous and grouped 
approaches with regression and SVA-correction for the individual pathways in KEGG database.  The distribution of the 
variability measures (∆var) for the genes within each pathway is represented as a box, encapsulating part of the distribution between 
1st and 3rd quantile, median of the box is colored in black. (A) represents variability measure distributions for the continuous, while (B) 
for the grouped approaches. Pathways on Y-axis and corresponding them boxes are ordered by increasing median. Boxes are colored in 
orange if the corresponding pathways have median ∆var > 0, and in blue, if median ∆var < 0. Text label on the plot shows percentage of 
pathways with median ∆var > 0. Red dashed line marks ∆var = 0, while black straight-line marks median across all the pathways. The 
mean values for the median across all pathways are 0.033 for ∆var(ρ)regression, 0.021 for ∆var(ρ)SVA, 0.033 for ∆var(IQR)regression, and 
0.027 for ∆var(IQR)SVA. 
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approaches create a challenge in interpretation, but they 
are not surprising given inherent differences in 
methodology and the small changes in variability we are 
investigating. 
 
Another technical aspect we considered was the effect 
of pre-processing steps. While applying regression and 
SVA corrections, we showed that significantly DV 
genes hardly overlap between the corrections, with only 
6% being in common (Jaccard similarity) (Figure 4A). 
Unfortunately, current approaches for handling 
transcriptome data are designed only to remove the 
confounding factors on the expression level and not on 
the expression variability. Thus, SVA and regression 
demonstrated much higher agreement in the 
differentially expressed (DE) genes (24% in common, 
Jaccard similarity) (Figure 1B). That raises a question: 
which set includes the genuine DV genes? The different 
correction strategies are quite distinct and might be 
accounting for different aspects, which is evident from 
the weak correlation between them (Spearman ρ  
between regression and SVA-corrected data for 
continuous approach – 0.35, grouped approach - 0.24, 
Supplemental Figure 6-7). In this case, the union may 
capture the full aspects of differential variability, 
whereas the overlap can provide the gene list in which 
we are most confident. 
 
Independent of the correction strategy, two-thirds of the 
DV genes showed a significant increase in variability. 
These results agree with the reports of Li et al. [10] on 
mice neural retina, but disagree with findings of 
Brinkmeyer-Langford et al. [11] on the human brain 
and Vinuela et al. [17] on the multiple human tissues 
which show either equal amount of genes increase and 
decrease in variability or more decrease than increase. 
The small overlap of our DV gene set with Brinkmeyer-
Langford et al. [11] (see Supplemental Information) 
could be explained by the technical aspects that we 
presented, i.e. variability measure and data pre-
processing, as well as use of different experimental 
setups and different age-ranges.  
 
We further asked if there is a shift towards an increase 
or decrease in variability (above or below zero) across 
the whole transcriptome, irrespective of the values and 
significance. In accordance with the previous findings 
on the human, rat and fruit fly [6,12,15], we found as 
many as 63% of genes showed increase in variability, 
whereas the value was lower for the grouped approach, 
i.e. 51%. Functional investigation of the differential 
variability showed that it is ubiquitous and was not 
concentrated in specific functional groups. That was 
further supported by the fact that as many as 74% to 
94% of KEGG pathways included more genes with an 
increase in variability (Figure 5 A, B). We further asked 
if certain individuals with extreme ages cause an 
increase in variability with age. Analyzing the 
variability (absolute value of residuals) for each 
individual for the top 100 genes with the highest change 
in variability (∆var(ρ)) in either direction (Supplemental 
Figure 14, 15), we showed that the pattern is not caused 
by a limited number of individuals but is a general 
trend. Interestingly, the increase in variability was not 
restricted to samples with extreme ages but started as 
soon as the age of 40.  
 
Most studies consider the accumulation of cellular 
damage, such as somatic mutations, with age as the 
main factor, causing increase in the gene expression 
variability with age. Indeed, Lodato et al [26] show 
increase in the number of single nucleotide variants in 
human brain with age, while Lee et al [27] documented 
somatic recombination of APP gene in human neurons 
and its increase with age. However, the causal link 
between the accumulation of mutations and increase in 
variability was not proven and Enge et al. [15] provide 
an evidence that somatic mutations are not enough to 
explain gene expression variability. Moreover, because 
brain is a post-mitotic tissue, it may demonstrate a 
different damage profile, as it is not as prone to 
replication-associated mutations as other tissues but 
associated with other types of damage, such as free 
radicals or loss of proteostasis. Notably, in this study we 
analyze different individuals; thus, the interpretation of 
the results could be different from the intra-individual 
variability which is observed across different cells from 
the same individual. If there are convergent 
mechanisms, more vulnerable cellular components, like 
hotspots, or transmission/propagation of signals that 
control the gene expression, interindividual 
heterogeneity could still reflect the changes at the 
cellular level. However, other explanations such as 
genotype differences, environment effects, and the 
difference in aging rates should be considered. A few 
studies have identified a small set of genetic variants 
that could change gene expression during aging 
(genotype-by-age interaction) [11,17,28]. However, 
these specific differences in genotype are not likely on 
their own to explain the transcriptome-wide shift that 
we observed. Still, we asked if the genes with a higher 
change in variability (∆var) are more or less tolerant to 
SNPs, using residual variation intolerance scores [29] 
which shows if a gene has more or fewer SNPs than 
expected (Supplemental Figure 13). There was no 
association between SNP tolerance and the change in 
variability, both when we considered and did not 
consider the direction of change (i.e. ∆var and absolute 
value of ∆var measures, respectively). The 
environmental factors influencing the epigenome, as 
well as stochastic effects driving an epigenetic drift 
[9,17,18,30] seems to be a likely explanation in this 
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case. Another explanation is that individuals age at 
different rates and we see more variability in the rate at 
older ages. However, in this case, the variability in 
different genes would be driven by the same individuals 
who age at different rates, which was not observed in 
our analysis (Supplemental Figure 14-15). The change 
in variability could also stem from the change in gene 
expression levels. Although not replicated in mouse 
brain [14], Davie et al.[12] show that aging leads to an 
overall decrease in the RNA content, which could also 
be the reason for such a global increase in the 
expression variability. However, we apply log2 
transformation, which attempts to correct the mean-
variability dependence. Indeed, we do not observe any 
significant association between the changes in 
expression level and variability (Odds ratio = 1.05, 
Fisher’s test p = 0.11, Supplemental Figure 10).   
 
Although we used one of the largest, well-characterized 
datasets, it is important to note that the sample size, the 
unequal coverage of ages and the high technical and 
biological variation all posed a challenge for the 
analysis. Moreover, this data was generated using 
microarray technology, which does not measure the 
expression of all genes and is not as quantitative as 
RNA-seq. Future studies addressing variability in gene 
expression may consider the use of scRNA-seq data to 
distinguish unique changes within a cell from the 
coordinated changes within cell population or changes 
in the cell composition. In order to gain insight into the 
potential contribution of the changes in cell composition 
to our results, we asked if there is an association 
between cell-type specific and DV genes (Supplemental 
Figure 12). We separated differentially variable genes 
based on the direction of change in variability, approach 
(grouped vs. continuous), and the correction strategy 
(regression vs. SVA). There was a significant overlap 
between genes with a decrease in variability and 
myelinated oligodendrocyte-specific genes. Also, 
oligodendrocyte progenitor- and neuron-specific genes 
showed significant overlap with genes that increase in 
variability, but this was not reproduced across different 
approaches or correction strategies. This analysis, 
however, cannot distinguish between if the change in 
cell composition drives the change in variability or if 
certain cell types become more variable with age; and 
we need cell-type specific age-series data to answer this 
question. Overall, the numbers of DV genes that 
overlapped with cell type-specific genes were low, and 
the changes in variability probably cannot be attributed 
only to the changes in cell type composition.  
 
Providing a systematic analysis of the same dataset at 
multiple levels and considering multiple technical 
challenges, we showed a slight but significant shift 
towards an age-related increase in variability that was 
not clustered in certain functions but distributed across 
all pathways. It has been recently suggested that an 
increase in expression variability is linked with the 
genetic risk for schizophrenia in males [31]. However, 
future experiments are crucial to understanding whether 
all genes, functions and organs are equally tolerant of 
the variability we observed and whether this variability 
has any causal relationship with the aging processes. 
 
MATERIALS AND METHODS 
 
Data processing steps 
 
Dataset selection: We utilized one of the largest age-
series human brain expression datasets, featuring 269 
prefrontal cortex samples from healthy individuals and 
spanning the whole lifespan from development (prenatal 
samples) through aging (80 years) [23]. These data were 
collected using microarray technology from people of 
both sexes and 4 races, namely African American (AA), 
Caucasian (CAUC), Hispanic (HISP) and Asian (AS). 
In the current analysis, we excluded fetal, childhood and 
early adulthood samples before the age of 20, thus 
limiting our sample size to 147. This was to exclude 
developmental processes taking place in the brain until 
the end of early adulthood, which exhibit discontinuous 
expression changes between early adulthood and aging 
[32]. Our main motivation was to study changes in gene 
expression variability during aging, considering 20 
years old as a starting point.  
 
Data characterization: The pre-processed data (loess 
normalization was applied on the background corrected 
log2 intensity ratios (sample/reference) [23]); sample 
and gene (probe set to Entrez gene mapping) 
annotations were obtained from the NCBI Gene 
Expression Omnibus (GEO) at accession number 
GSE30272. Samples were processed in 19 batches, had 
different quality measurements, namely pH and RNA 
integrity number (RIN), and differed in the time of 
collection after death (post-mortem interval (PMI)). 
Using a PCA, we found no sample outliers as judged by 
visual inspection of the first two principal components 
(Supplemental Figure 2). However, the relationship 
analysis between the above-mentioned factors (i.e. 
batch, RIN, PMI and others) and age yielded significant 
correlations for sex, post-mortem interval and RNA 
integrity, pointing to potential confounders in the data 
(Supplemental Figure 1). We further checked the 
overlap between significantly differentially variable 
genes in our analysis and previously reported genes that 
are affected by PMI and detected only a limited overlap 
(see Supplemental Information).   
 
Probe set to Gene summarization: If one probe-set was 
mapped to several genes, it was deleted to avoid 
duplication. Conversely, when one gene had several 
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probe-set expression values, they were averaged to 
obtain a unique gene expression value. In total 16675 
genes were measured on the array.  
 
Batch correction: To compensate for technical 
variation between samples, quantile normalization (QN) 
was performed using the ‘normalise.quantiles’ function 
from the ‘preprocessCore’ R library. To differentiate 
between the age effect and the effect of the unwanted 
technical and biological variability, we have applied 
different expression correction strategies: linear 
regression of the known covariates, unsupervised 
estimation of covariates using surrogate variable 
analysis (SVA) [25,33], and ComBat, a parametric 
empirical Bayesian framework for covariate adjustment 
[24]. As a result, we analyzed the same data four times, 
corrected using QN, QN+regression, QN+SVA, 
QN+ComBat. Different corrections work by adjusting 
for the different covariates in the linear model that 
explains the gene expression, namely: i) QN – no 
covariates were added; ii) QN+regression – 25 
covariates considered: technical batches (N = 19), sex 
(N=2), race (N=4), post-mortem interval, RNA integrity 
number,pH; iii) QN + SVA – 20 surrogate variables 
(SV) were inferred from the expression data using the 
‘sva’ function from “SVA” R library; iv) QN+ComBat: 
the 6 confounding factors: batch (N = 19), sex (N=2), 
race(N=4), PMI, RIN and pH were adjusted for, one at 
the time, by repeatedly applying the ComBat function 
from the “SVA” R library to the expression data.   
 
Differential expression  
 
A least squares linear regression model was used to 
model gene expression level change with age. Age0.25 
was used as an independent variable instead of age to 
account for the difference in the rate of gene expression 
changes between young (fast) and old (slow) as well as 
different density of the samples across ages. 
Nevertheless, the β1- coefficients from the linear model, 
that uses age0.25 correlate well with the one, that employs 
age (Supplemental Figure 4). Coefficients for the age 
covariate were used as a measure of the differential 
expression. P values for coefficients were adjusted using 
the FDR method with a threshold p ≤ 0.05 to account for 
multiple testing.  Depending on the correction method 
applied, the linear model also accounted for different 
measured or unmeasured covariates (see Data processing 
steps) of the following general form:  
 
𝑌𝑌𝑖𝑖 =  𝛽𝛽𝑖𝑖0 + 𝛽𝛽𝑖𝑖1 ∗ 𝑎𝑎𝑎𝑎𝑎𝑎0.25 + 𝑐𝑐𝑐𝑐𝑐𝑐𝑎𝑎𝑐𝑐𝑐𝑐𝑎𝑎𝑐𝑐𝑎𝑎𝑐𝑐 + 𝜀𝜀𝑖𝑖, 
 
where 𝑌𝑌𝑖𝑖 is the normalized log-expression level of a 
gene with i = 1,…,n, 𝛽𝛽𝑖𝑖0- intercept, 𝛽𝛽𝑖𝑖1- slope term and 
𝜀𝜀𝑖𝑖 - residual (or error) term. 
 
Differential variability 
 
The continuous approach: First, a linear model to fit 
gene expression during aging, using age0.25 and potential 
confounders, was constructed. Next, the Spearman 
correlation was calculated between the absolute values 
of the residuals, |εi| from the linear model and age. 
Consequently, Spearman correlation estimates were 
used as a measure of the change in variability, referred 
as ∆vari(ρ). P values for the Spearman correlation 
estimates were corrected for multiple testing using 
FDR. FDR adjusted p ≤ 0.05 was used as a threshold to 
define significantly DV genes. 
 
Δ𝑐𝑐𝑎𝑎𝑐𝑐𝑖𝑖  (𝜌𝜌) =  𝑆𝑆𝑆𝑆𝑎𝑎𝑎𝑎𝑐𝑐𝑆𝑆𝑎𝑎𝑆𝑆 𝜌𝜌 (|𝜀𝜀𝑖𝑖|,𝑎𝑎𝑎𝑎𝑎𝑎) 
 
The grouped approach: First, a corrected expression 
matrix was obtained by removing the effect of 
covariates (see data processing steps) from the data 
using the residuals from a linear regression model (Yi = 
βi0 + covariates + ε). The ‘grouped approach’ is a 
custom resampling-based test designed to compare gene 
expression variability between young (20 – 40 years 
old) and old (60-80 years old) groups using an 
interquartile range (IQR). IQR corresponds to the 
difference between the 75th and 25th percentiles of the 
distribution and is considered to be a robust measure of 
variability, meaning it is not susceptible to outliers and 
departure from normality in the data. In order to adjust 
for the unequal sample size of the young (N = 53) and 
old (N = 22) groups, we, first, calculated a null 
distribution of the IQR values for the young group by 
resampling it 10 000 times with the size of the old 
group. Next, we calculated significance as a percentage 
of samples where IQRold was more extreme than 
IQRyoung and corrected it for multiple testing using FDR 
correction, q ≤ 0.05. The ‘grouped’ measure of change 
in the variability, ∆vari(IQR), for the gene 
𝑐𝑐, corresponds to the difference between IQR value for 
the old, 𝐼𝐼𝐼𝐼𝐼𝐼𝑖𝑖 𝑜𝑜𝑜𝑜𝑜𝑜  , and 𝐼𝐼𝐼𝐼𝐼𝐼𝚤𝚤 𝑦𝑦𝑜𝑜𝑦𝑦𝑦𝑦𝑦𝑦������������� (i.e. mean IQR value 
from the young distribution), which is then divided by 
the latter, see formula:  
 
Δ𝑐𝑐𝑎𝑎𝑐𝑐𝑖𝑖  (𝐼𝐼𝐼𝐼𝐼𝐼) =  �𝐼𝐼𝐼𝐼𝐼𝐼𝑖𝑖 𝑜𝑜𝑜𝑜𝑜𝑜 −  𝐼𝐼𝐼𝐼𝐼𝐼𝚤𝚤 𝑦𝑦𝑜𝑜𝑦𝑦𝑦𝑦𝑦𝑦�������������� 𝐼𝐼𝐼𝐼𝐼𝐼𝚤𝚤 𝑦𝑦𝑜𝑜𝑦𝑦𝑦𝑦𝑦𝑦��������������  
 
Gene Set Enrichment Analysis for KEGG pathways 
and GO categories  
 
β1 coefficients from the differential expression and ∆var 
measures from the differential variability analyses were 
used to perform gene set enrichment analysis, GSEA 
[34] using the “clusterProfiler” R library. KEGG 
pathways (N = 315) and BP GO terms (Biological 
processes Gene Ontology, N = 5822) with the size of 
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between 10 and 500 genes were considered as gene sets 
for the GSEA.  
 
Pathway distribution study  
 
KEGG pathway to gene mapping was obtained from 
“KEGGREST” R library and pathways were pre-filtered 
to contain between 5 and 500 genes. As a result, 310 
KEGG pathways that comprise 5922 unique genes were 
used for the subsequent analysis. The boxplots 
illustrated distributions of the ∆var measure for genes in 
each pathway. Pathways were sorted according to their 
median ∆var measure in ascending order. The 
percentage of pathways that have their median ∆var 
above zero was calculated. The analysis was replicated 
using BP GO terms (N = 5919) of a size between 10 and 
500 genes, which in total contained 12538 unique 
genes. Mapping of GO terms to genes was obtained 
from “org.Hs.eg.db” R library. 
 
Distribution tests  
 
Distributions of the ∆var - measures for all the genes 
were tested for normality using the Shapiro-Wilk test in 
R (‘Shapiro.test’ function) on the multiple subsamples, 
consisting of 5000 measures. Skewness of the 
distributions was calculated using the ‘fBasics’ function 
from “BasicStatistics” R library.  
 
Mean-variability relationship testing  
 
To visualize and test if the change in gene expression 
variability is associated with the change in gene 
expression level, we plotted the difference in the means 
between the young and old groups against difference in 
the interquartile range (IQR) between the young and old 
groups. Mean and IQR for the old group were 
calculated once, while mean and IQR for the young 
group were calculated 10,000 times for the subsamples 
(see Grouped approach) and then means of the 
distributions of the corresponding values (mean and 
IQR) were used in the analysis. Fisher’s exact test was 
performed on the values used for the plotting.  
 
Functional variation intolerance – variability 
relationship 
 
To test if there is a relationship between age-dependent 
change in variability and how tolerant a gene is to 
functional variations, we used residual variation 
intolerance (RVI) percentages based on ExAC v2 data 
[29]. RVI percentage shows whether genes have more 
or less common functional genetic variation relative to 
the genome wide expectation. A gene with a higher 
percentage has more common functional variation 
whereas a lower percentage shows the genes that are 
intolerant to functional variation. We tested the 
association using the Spearman’s correlation coefficient 
between the ∆var measures and RVI percentages, for 
different approaches and correction strategies, 
separately.  
 
Cell type-specific genes  
 
In order to test if the changes in cell type composition 
can drive the changes in heterogeneity, we tested the 
association between cell-type specific and DV genes. 
First, we analyzed a cell-type specific transcriptome 
dataset (GSE9566) [35] which has expression profiles 
for FACS purified cell types in the mouse brain. Data is 
downloaded from GEO database [36], RMA corrected 
using ‘affy’ package in R [37], log2 transformed, and 
quantile normalized using ‘preprocessCore’ package in 
R [38]. Only the genes with 1 to 1 human orthologs in 
Ensembl Compara [39] are used. We used ‘biomaRt’ 
package in R [40] to retrieve the mapping between 
probesets and genes. When there is more than one gene 
that map to a single probeset, we discarded those from 
the analysis. If multiple probesets represent one gene, 
we used the mean expression value of these probesets to 
calculate gene expression level. To define cell-type 
specific genes, for each human ortholog, we first 
standardized the gene expression values, and calculated 
the effect size of each cell type (oligodendrocytes, 
myelinated oligodendrocytes, oligodendrocyte 
progenitors, astrocytes and neurons) and identified 
genes with an effect size higher than 2 to a particular 
cell type. Using this cutoff, cell type-specific gene lists 
did not overlap. We next tested for the overlaps between 
these cell type-specific and differentially variable gene 
lists, using Fisher’s exact test.  
 
Software 
 
R version 3.5.0 and “data.table” were used to perform 
the analyses, while “ggplot2” and “ggpubr” R libraries 
were used to create visualizations of the data. 
 
Abbreviations 
 
BP GO: Biological Process Gene Ontology; DE: 
differentially expressed genes; DV: differentially 
variable genes; ∆var: the measure of change in the 
expression variability with age; GO: Gene Ontology; 
GSEA: Gene Set Enrichment Analysis; IQR: 
interquartile range; KEGG: Kyoto Encyclopedia of 
Genes and Genomes; PMI: post-mortem interval; QN: 
quantile normalization; RIN: RNA integrity number; 
Rho: Spearman correlation estimate; SVA: Surrogate 
Variable Analysis  
www.aging-us.com 2264 AGING 
AUTHOR CONTRIBUTIONS 
 
H.M.D, V.R.K and J.M.T designed the study. V.R.K 
and H.M.D analyzed the data. V.R.K, H.M.D and J.M.T 
interpreted the results and wrote the manuscript. All 
authors read, revised and approved the final version of 
this manuscript. 
 
ACKNOWLEDGMENTS 
 
The authors thank to Dr. Mehmet Somel, Dr. John 
Marioni and the members of Thornton group, especially 
Dr. Dobril Ivanov and Daniel Elias Martin Herranz for 
their support and helpful discussions and to Matías 
Fuentealba Valenzuela for critical reading of the 
manuscript. H.M.D is a member of Darwin College, 
University of Cambridge. 
 
CONFLICTS OF INTEREST 
 
The authors have no conflict of interest to declare. 
 
FUNDING 
 
This work was funded by EMBL (V.R.K, H.M.D., 
J.M.T.) and the Wellcome Trust [098565/Z/12/Z] 
(J.M.T). 
 
REFERENCES 
 
1. Herndon LA, Schmeissner PJ, Dudaronek JM, Brown 
PA, Listner KM, Sakano Y, Paupard MC, Hall DH, 
Driscoll M. Stochastic and genetic factors influence 
tissue-specific decline in ageing C. elegans. Nature. 
2002; 419:808–14.  
https://doi.org/10.1038/nature01135 
2. Kirkwood TB, Feder M, Finch CE, Franceschi C, 
Globerson A, Klingenberg CP, LaMarco K, Omholt S, 
Westendorp RG. What accounts for the wide 
variation in life span of genetically identical 
organisms reared in a constant environment? Mech 
Ageing Dev. 2005; 126:439–43.  
https://doi.org/10.1016/j.mad.2004.09.008 
3.  Horvath S. DNA methylation age of human tissues 
and cell types. Genome Biol. 2013; 14:R115. 
https://doi.org/10.1186/gb-2013-14-10-r115 
4.  Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, 
Ballestar ML, Heine-Suñer D, Cigudosa JC, Urioste M, 
Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling 
C, et al. Epigenetic differences arise during the 
lifetime of monozygotic twins. Proc Natl Acad Sci 
USA. 2005; 102:10604–09.  
https://doi.org/10.1073/pnas.0500398102 
5.  Cheung P, Vallania F, Warsinske HC, Donato M, 
Schaffert S, Chang SE, Dvorak M, Dekker CL, Davis 
MM, Utz PJ, Khatri P, Kuo AJ. Single-Cell Chromatin 
Modification Profiling Reveals Increased Epigenetic 
Variations with Aging. Cell. 2018; 173:1385–
1397.e14. https://doi.org/10.1016/j.cell.2018.03.079 
6.  Somel M, Khaitovich P, Bahn S, Pääbo S, Lachmann 
M. Gene expression becomes heterogeneous with 
age. Curr Biol. 2006; 16:R359–60.  
https://doi.org/10.1016/j.cub.2006.04.024 
7.  Bahar R, Hartmann CH, Rodriguez KA, Denny AD, 
Busuttil RA, Dollé ME, Calder RB, Chisholm GB, 
Pollock BH, Klein CA, Vijg J. Increased cell-to-cell 
variation in gene expression in ageing mouse heart. 
Nature. 2006; 441:1011–14.  
https://doi.org/10.1038/nature04844 
8.  Martinez-Jimenez CP, Eling N, Chen HC, Vallejos CA, 
Kolodziejczyk AA, Connor F, Stojic L, Rayner TF, 
Stubbington MJ, Teichmann SA, de la Roche M, 
Marioni JC, Odom DT. Aging increases cell-to-cell 
transcriptional variability upon immune stimulation. 
Science. 2017; 355:1433–36.  
https://doi.org/10.1126/science.aah4115 
9.  Hernando-Herraez I, Evano B, Stubbs T, Commere 
PH, Clark S, Andrews S, Tajbakhsh S, Reik W. Ageing 
affects DNA methylation drift and transcriptional 
cell-to-cell variability in muscle stem cells. bioRxiv. 
2018; 500900. https://doi.org/10.1101/500900 
10.  Li Z, Wright FA, Royland J. Age-dependent variability 
in gene expression in male Fischer 344 rat retina. 
Toxicol Sci. 2009; 107:281–92.  
https://doi.org/10.1093/toxsci/kfn215 
11.  Brinkmeyer-Langford CL, Guan J, Ji G, Cai JJ. Aging 
Shapes the Population-Mean and -Dispersion of 
Gene Expression in Human Brains. Front Aging 
Neurosci. 2016; 8:183.  
https://doi.org/10.3389/fnagi.2016.00183 
12.  Davie K, Janssens J, Koldere D, De Waegeneer M, 
Pech U, Kreft Ł, Aibar S, Makhzami S, Christiaens V, 
Bravo González-Blas C, Poovathingal S, Hulselmans 
G, Spanier KI, et al. A Single-Cell Transcriptome Atlas 
of the Aging Drosophila Brain. Cell. 2018; 174:982–
998.e20. https://doi.org/10.1016/j.cell.2018.05.057 
13.  Angelidis I, Simon LM, Fernandez IE, Strunz M, Mayr 
CH, Greiffo FR, Tsitsiridis G, Graf E, Strom TM, 
Eickelberg O, Mann M, Theis FJ, Schiller HB. An atlas 
of the aging lung mapped by single cell transcript-
omics and deep tissue proteomics. Nat Commun. 
2019; 10:963.  
https://doi.org/10.1038/s41467-019-08831-9 
www.aging-us.com 2265 AGING 
14.  Ximerakis M, Lipnick SL, Simmons SK, Adiconis X, 
Innes BT, Dionne D, Nguyen L, Mayweather BA, Ozek 
C, Niziolek Z, Butty VL, Isserlin R, Buchanan SM, et al. 
Single-cell transcriptomics of the aged mouse brain 
reveals convergent, divergent and unique aging 
signatures. bioRxiv. 2018; 440032.  
https://doi.org/10.1101/440032 
15.  Enge M, Arda HE, Mignardi M, Beausang J, Bottino R, 
Kim SK, Quake SR. Single-Cell Analysis of Human 
Pancreas Reveals Transcriptional Signatures of Aging 
and Somatic Mutation Patterns. Cell. 2017; 171:321–
330.e14. https://doi.org/10.1016/j.cell.2017.09.004 
16.  Wiley CD, Flynn JM, Morrissey C, Lebofsky R, Shuga J, 
Dong X, Unger MA, Vijg J, Melov S, Campisi J. 
Analysis of individual cells identifies cell-to-cell 
variability following induction of cellular senescence. 
Aging Cell. 2017; 16:1043–50.  
https://doi.org/10.1111/acel.12632 
17.  Viñuela A, Brown AA, Buil A, Tsai PC, Davies MN, Bell 
JT, Dermitzakis ET, Spector TD, Small KS. Age-
dependent changes in mean and variance of gene 
expression across tissues in a twin cohort. Hum Mol 
Genet. 2018; 27:732–41.  
https://doi.org/10.1093/hmg/ddx424 
18.  Slieker RC, van Iterson M, Luijk R, Beekman M, 
Zhernakova DV, Moed MH, Mei H, van Galen M, 
Deelen P, Bonder MJ, Zhernakova A, Uitterlinden AG, 
Tigchelaar EF, et al, and BIOS consortium. Age-
related accrual of methylomic variability is linked to 
fundamental ageing mechanisms. Genome Biol. 
2016; 17:191. https://doi.org/10.1186/s13059-016-
1053-6 
19.  Inukai S, Pincus Z, de Lencastre A, Slack FJ. A 
microRNA feedback loop regulates global microRNA 
abundance during aging. RNA. 2018; 24:159–72. 
https://doi.org/10.1261/rna.062190.117 
20.  Warren LA, Rossi DJ, Schiebinger GR, Weissman IL, 
Kim SK, Quake SR. Transcriptional instability is not a 
universal attribute of aging. Aging Cell. 2007; 6:775–
82.  
https://doi.org/10.1111/j.1474-9726.2007.00337.x 
21.  Southworth LK, Owen AB, Kim SK. Aging mice show a 
decreasing correlation of gene expression within 
genetic modules. PLoS Genet. 2009; 5:e1000776. 
https://doi.org/10.1371/journal.pgen.1000776 
22.  Oh G, Ebrahimi S, Wang SC, Cortese R, Kaminsky ZA, 
Gottesman II, Burke JR, Plassman BL, Petronis A. 
Epigenetic assimilation in the aging human brain. 
Genome Biol. 2016; 17:76.  
https://doi.org/10.1186/s13059-016-0946-8 
23.  Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek 
JT, Colantuoni EA, Elkahloun AG, Herman MM, 
Weinberger DR, Kleinman JE. Temporal dynamics 
and genetic control of transcription in the human 
prefrontal cortex. Nature. 2011; 478:519–23. 
https://doi.org/10.1038/nature10524 
24.  Johnson WE, Li C, Rabinovic A. Adjusting batch 
effects in microarray expression data using empirical 
Bayes methods. Biostatistics. 2007; 8:118–27. 
https://doi.org/10.1093/biostatistics/kxj037 
25.  Leek JT, Storey JD. Capturing heterogeneity in gene 
expression studies by surrogate variable analysis. 
PLoS Genet. 2007; 3:1724–35.  
https://doi.org/10.1371/journal.pgen.0030161 
26.  Lodato MA, Rodin RE, Bohrson CL, Coulter ME, 
Barton AR, Kwon M, Sherman MA, Vitzthum CM, 
Luquette LJ, Yandava CN, Yang P, Chittenden TW, 
Hatem NE, et al. Aging and neurodegeneration are 
associated with increased mutations in single human 
neurons. Science. 2018; 359:555–59.  
https://doi.org/10.1126/science.aao4426 
27.  Lee MH, Siddoway B, Kaeser GE, Segota I, Rivera R, 
Romanow WJ, Liu CS, Park C, Kennedy G, Long T, 
Chun J. Somatic APP gene recombination in 
Alzheimer’s disease and normal neurons. Nature. 
2018; 563:639–45. https://doi.org/10.1038/s41586-
018-0718-6 
28.  Kent JW Jr, Göring HH, Charlesworth JC, Drigalenko 
E, Diego VP, Curran JE, Johnson MP, Dyer TD, Cole 
SA, Jowett JB, Mahaney MC, Comuzzie AG, Almasy L, 
et al. Genotype×age interaction in human 
transcriptional ageing. Mech Ageing Dev. 2012; 
133:581–90. 
https://doi.org/10.1016/j.mad.2012.07.005 
29.  Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein 
DB. Genic intolerance to functional variation and the 
interpretation of personal genomes. PLoS Genet. 
2013; 9:e1003709.  
https://doi.org/10.1371/journal.pgen.1003709 
30.  Pal S, Tyler JK. Epigenetics and aging. Sci Adv. 2016; 
2:e1600584. 
https://doi.org/10.1126/sciadv.1600584 
31.  Chen J, Cao H, Meyer-Lindenberg A, Schwarz E. Male 
increase in brain gene expression variability is linked 
to genetic risk for schizophrenia. Transl Psychiatry. 
2018; 8:140. https://doi.org/10.1038/s41398-018-
0200-0 
32.  Dönertaş HM, İzgi H, Kamacıoğlu A, He Z, Khaitovich 
P, Somel M. Gene expression reversal toward pre-
adult levels in the aging human brain and age-related 
www.aging-us.com 2266 AGING 
loss of cellular identity. Sci Rep. 2017; 7:5894. 
https://doi.org/10.1038/s41598-017-05927-4 
33.  Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. 
The sva package for removing batch effects and 
other unwanted variation in high-throughput 
experiments. Bioinformatics. 2012; 28:882–83. 
https://doi.org/10.1093/bioinformatics/bts034 
34.  Subramanian A, Tamayo P, Mootha VK, Mukherjee S, 
Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, 
Golub TR, Lander ES, Mesirov JP. Gene set 
enrichment analysis: a knowledge-based approach 
for interpreting genome-wide expression profiles. 
Proc Natl Acad Sci USA. 2005; 102:15545–50. 
https://doi.org/10.1073/pnas.0506580102 
35.  Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, 
Christopherson KS, Xing Y, Lubischer JL, Krieg PA, 
Krupenko SA, Thompson WJ, Barres BA. A 
transcriptome database for astrocytes, neurons, and 
oligodendrocytes: a new resource for understanding 
brain development and function. J Neurosci. 2008; 
28:264–78. 
https://doi.org/10.1523/JNEUROSCI.4178-07.2008 
36.  Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, 
Tomashevsky M, Marshall KA, Phillippy KH, Sherman 
PM, Holko M, Yefanov A, Lee H, Zhang N, et al. NCBI 
GEO: archive for functional genomics data sets--
update. Nucleic Acids Res. 2013; 41:D991–95.  
https://doi.org/10.1093/nar/gks1193 
37.  Gautier L, Cope L, Bolstad BM, Irizarry RA. affy--
analysis of Affymetrix GeneChip data at the probe 
level. Bioinformatics. 2004; 20:307–15.  
https://doi.org/10.1093/bioinformatics/btg405 
38.  Bolstad BM. preprocessCore: A collection of pre-
processing functions. 2016.  
https://bioconductor.riken.jp/packages/3.0/bioc/ht
ml/preprocessCore.html 
39.  Vilella AJ, Severin J, Ureta-Vidal A, Heng L, Durbin R, 
Birney E. EnsemblCompara GeneTrees: Complete, 
duplication-aware phylogenetic trees in vertebrates. 
Genome Res. 2009; 19:327–35.  
https://doi.org/10.1101/gr.073585.107 
40.  Durinck S, Moreau Y, Kasprzyk A, Davis S, De Moor B, 
Brazma A, Huber W. BioMart and Bioconductor: a 
powerful link between biological databases and 
microarray data analysis. Bioinformatics. 2005; 
21:3439–40. 
https://doi.org/10.1093/bioinformatics/bti525 
  
www.aging-us.com 2267 AGING 
SUPPLEMENTARY MATERIAL 
 
Please browse the links in Full Text version of this manuscript to see Supplementary Tables 1-7. 
 
Supplemental Table 1. The results of the differential expression analysis performed on regression-corrected and 
SVA-corrected data.  
Supplemental Table 2. The results of the GSEA Analysis for BP GO categories performed on the differentially 
expressed genes obtained on regression-corrected and SVA-corrected data.  
Supplemental Table 3. The results of the differential variability analysis while applying “continuous approach” 
for the regression and SVA-corrected expression data.  
Supplemental Table 4. The results of the differential variability analysis while applying “grouped approach” for 
the regression and SVA-corrected expression data. 
Supplemental Table 5. The results of GSEA Analysis among the KEGG pathways on the differential variability 
measures from the "continuous" and "grouped" approaches. 
Supplemental Table 6. The results of GSEA Analysis among the GO categories on the differential variability 
measures from the "continuous" and "grouped" approaches. 
Supplemental Table 7. The median variability measures for the genes within each KEGG pathway and GO term, 
using different approaches.  
 
 
Supplemental Information  
 
Post-mortem interval associated differentially variable 
genes 
 
Recent reports made on the GTEx data [1] suggest that 
extent of Post-mortem interval (PMI) – the time passed 
between death and sample collection, could be associated 
with the degradation of specific mRNA species and, 
consequently, change in both mean and variability of their 
gene expression. We have checked whether our set of 
differentially variable genes (DV) contains any of the 
reported 266 genes that are susceptible to the degradation 
dependent on PMI. We found 14, 14, 10 and 7 of those 
genes among the set of differentially variable genes 
identified in the grouped approach with quantile 
normalization, regression, ComBat and SVA correction, 
respectively.  
 
Overlap of the DV genes with other publications 
 
The total set of differentially variable genes identified by 
Brinkmeyer-Langford [2] comprises 848 distinct genes 
found across 13 brain regions. 171 of those genes are 
specific to the cortex and frontal cortex. Our set of DV 
genes found in grouped approach after regression 
correction (N total = 741) has an overlap of 21 genes with 
Brinkmeyer-Langford and 19 genes for the SVA-
corrected expression (N total = 746). The percentage of 
overlap doesn’t increase, if we only consider cortex-
specific DV genes from Brinkmeyer-Langford - it 
constitutes 4 and 3 genes for regression and SVA 
corrected sets, respectively. 
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Supplemental Table 8. Percentage of KEGG pathways and GO terms that have median expression variability 
above 0, according to different approaches. 
 Continuous approach Grouped approach 
 Regression SVA QN ComBat Regression SVA QN ComBat 
KEGG pathways 94% 88% 99% 88% 77% 74% 94% 95% 
GO terms 92% 84% 98% 79% 66% 61% 88% 88% 
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Supplemental Figures 
 
 
 
 
 
 
Supplemental Figure  1. Dependency plots between the age and different biological and technical factors, such as batch, 
sex, race, post-mortem interval (PMI), pH and RNA integrity number (RIN). Box plots were constructed for categorical covariates 
(batch, sex and race), while scatter plots were made for the numerical covariates (PMI, pH, RIN). In order to test for the significance of the 
dependence between categorical covariates and age ANOVA-test was performed (p value is displayed on the graph), Spearman correlation 
estimate was calculated to estimate relationship between numerical covariates and age (Spearman rho and p value are displayed on the 
graph). * p ≤ 0.05 
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Supplemental Figure  2. PCA plots of the raw expression data and after different pre-processing steps.  First row from left to 
right: probe expression level, gene expression level and quantile normalized gene expression level. Second row from left to right: quantile 
normalized data further corrected either with regression, ComBat or SVA. Color gradient depicts age range from pink – young to violet – 
old. 
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Supplemental Figure 3. (A) Illustration of the relationship between beta1 – coefficients from the linear regression models that explain 
gene expression corrected with different approaches (QN only, QN followed by regression, ComBat, SVA) using age0.25. Scatter plots that 
illustrate relationship between the beta1 – coefficients from different corrections are displayed in the lower triangle of the matrix, 
distributions of the beta1 – coefficients are located on the diagonal and Spearman correlation estimates are displayed in the upper triangle 
of the matrix. (B) Venn diagram of the differentially expressed (DE) genes with age that were identified after applying different expression 
correction approaches (QN only, QN followed by regression, ComBat, SVA). The ComBat approach seem to greatly outnumber all the other 
approaches in the number of DE genes. We consider that consecutive application (6 times) of the linear model that contains age and 
particular confounding factor caused an overfitting of gene expression with age and lead to identification of so many DE genes, many of 
which are false positives. 
 
B 
A 
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Supplemental Figure 4. Scatter plots of the dependency between beta1 coefficients from the linear regression models that 
explain gene expression using age in comparison to age0.25. Gene expression was corrected using ComBat (A), QN only (B), 
regression (C) and SVA (D). Linear regression line between the variables (in red) and Spearman correlation estimate is shown on the graph.  
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Supplemental Figure 5. Comparison of the distributions of the differential variability measures, ∆var (ρ) and ∆var (IQR), 
obtained in the expression data corrected with QN, Regression, SVA and ComBat. The black straight line depicts zero, the red 
dashed line – median of the distribution. 
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Supplemental Figure 6. Combination of comparisons of the variability measures (Δvar) obtained in the continuous 
approach between different ways of data pre-processing. Correction with quantile normalization only, linear regression, SVA and 
ComBat. Scatter plots between the differential variability measures obtained after different corrections are displayed in the lower triangle 
of the matrix, distributions of the differential variability measures are located on the diagonal and Spearman correlation estimates between 
the variability measures from different corrections are shown in the upper triangle of the matrix.  
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Supplemental Figure 7. Combination of comparisons of the variability measures (Δvar) obtained in the grouped approach 
between different ways of data pre-processing. Correction with quantile normalization only, linear regression, SVA and ComBat.  
Scatter plots between the differential variability measures obtained after different corrections are displayed in the lower triangle of the 
matrix, distributions of the differential variability measures are located on the diagonal and Spearman correlation estimates between the 
differential variability measures from different corrections are shown in the upper triangle of the matrix.  
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Supplemental Figure 8. Venn diagram of the differentially variable genes found in the grouped approach when expression 
data was corrected with QN, linear regression, SVA and ComBat. 
 
 
 
 
 
Supplemental Figure 9. Scatter plots of the relationship between the change in the variability measures for the continuous 
and grouped approaches in data, corrected with QN, ComBat, regression and SVA corrections. Linear regression line between 
the variables (in red) and Spearman correlation estimate are shown on the graph.    
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Supplemental Figure 10. Relationship between the change in gene expression level and variability. x axis depicts difference 
between mean of the old group and mean of the young group distribution (generated by resampling young group with sample size of 22 for 
10,000 times and calculating the mean), y axis illustrates difference between interquartile range (IQR) for the old and mean IQR from the 
young distribution (generated by resampling young group with sample size of 22 for 10,000 times and calculating IQR).  
 
 
 
 
 
 
Supplemental Figure 11. Scatter plots that illustrate relationship between the pathway membership of a gene and its 
change in variability measure for the continuous and grouped approaches in data corrected with regression and SVA. Linear 
regression line between the variables is shown red on the graph. 
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Supplemental Figure 12. A heatmap showing the significant association between differentially variable and cell-type 
specific genes. Rows show different cell-types and columns show genes detected as differentially variable based on different approaches 
(grouped (gr_) or continuous (cont_)), correction methods (regression (regres_) or SVA) and direction of change (increase (u) or decrease 
(d)). The color shows log2(odds ratio) for the enrichment of a particular category in cell-type specific genes. All non-significant (p > 0.05) 
values are discarded and shown as white. Since there are no significantly differentially variable gene detected based on continuous 
approach, we took the first 1% of genes with the highest change in variability as the DV genes for this analysis. The number of genes tested 
for each cell type were as follows: oligodendrocyte progenitors 396, oligodendrocytes 64, astrocytes 21, myelinated oligodendrocytes 448, 
neurons 340. 
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Supplemental Figure 13.  Scatter plot showing the association between the change in variability with age (y-axis) and 
residual variation intolerance (RVI) percentage (x-axis), which shows whether genes have more or less common functional 
genetic variation relative to the genome wide expectation. A gene with a positive score has more common functional variation 
whereas a negative score shows the genes that are intolerant to functional variation. The scores are than assigned percentiles in decreasing 
order of scores, so that a higher score (genes having more common functional variation) is given a higher percentile. Each point shows a 
gene and the black line is the best fit line depicted for visualization purposes. The correlation between change in variability with age and 
RVI percentage is calculated using Spearman’s correlation and the coefficient is given for each plot. The same analysis was repeated for the 
absolute value of the change in variability and also only using the significantly DV genes and the results are comparable with Spearman’s 
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correlation coefficient ranging between -0.03 and 0.01 (graphs are not shown).  
 
 
 
Supplemental Figure 14. A heatmap visualizing the variability for each individual (columns), and top 100 genes with the 
highest change in variability in either direction (rows) based on continuous approach and regression correction. The color 
shows the rank of individuals with respect to their variability for that particular gene. Darker colors show individuals with the highest 
variability for that particular gene. Genes are clustered using hierarchical clustering and individuals are ordered by age.  
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Supplemental Figure 15. Same as Supplemental Figure 14 but for continuous approach using SVA correction. 
 
